Gong J, Chen D, Kashiwaba M, Li Y, Chen L, Takeuchi H, Qu H, Rowse G J, Gendler S J, Kufe D
Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6279-83. doi: 10.1073/pnas.95.11.6279.
Immunological unresponsiveness established by the elimination or anergy of self-reactive lymphocyte clones is of importance to immunization against tumor-associated antigens. In this study, we have investigated induction of immunity against the human MUC1 carcinoma-associated antigen in MUC1 transgenic mice unresponsive to MUC1 antigen. Immunization of adult MUC1 transgenic mice with irradiated MUC1-positive tumor cells was unsuccessful in reversing unresponsiveness to MUC1. By contrast, fusions of dendritic cells with MUC1-positive tumor cells induced cellular and humoral immunity against MUC1. Immunization with the dendritic cell fusions that express MUC1 resulted in the rejection of established metastases and no apparent autoimmunity against normal tissues. These findings demonstrate that unresponsiveness to the MUC1 tumor-associated antigen is reversible by immunization with heterokaryons of dendritic cells and MUC1-positive carcinoma cells.
通过清除自身反应性淋巴细胞克隆或使其无反应性所建立的免疫无反应性,对于针对肿瘤相关抗原的免疫接种具有重要意义。在本研究中,我们调查了在对MUC1抗原无反应的MUC1转基因小鼠中诱导针对人MUC1癌相关抗原的免疫反应。用经辐照的MUC1阳性肿瘤细胞免疫成年MUC1转基因小鼠,未能成功逆转对MUC1的无反应性。相比之下,树突状细胞与MUC1阳性肿瘤细胞的融合诱导了针对MUC1的细胞免疫和体液免疫。用表达MUC1的树突状细胞融合体进行免疫,导致已形成的转移灶被排斥,且未出现针对正常组织的明显自身免疫反应。这些发现表明,用树突状细胞与MUC1阳性癌细胞的异核体进行免疫接种可逆转对MUC1肿瘤相关抗原的无反应性。